Author

G. Zhang

Observed names: G. ZHANG, Guojie Zhang

Institution: Shaoxing People's Hospital

Observed institutions: Chinese PLA General Hospital, Wuhan University, Zhongnan Hospital of Wuhan University, Lanzhou University Second Hospital, Shaoxing People's Hospital

ORCID: 0009-0005-2160-932X

Observed ORCID: 0009-0005-2160-932X

OpenAlex ID: A5011937628

CD 39+ regulatory T cells attenuate allergic airway inflammation

2015 · P. Li, Y. Gao, et al. · Clinical & Experimental Allergy · 48

Long-term survival of patients with hepatocellular carcinoma with pulmonary and adrenal metastasis: A case report

2012 · H.Y. ZHANG, Q.J. WU, et al. · Experimental and Therapeutic Medicine · 5

Population Sensitive to Lenvatinib Plus Anti-PD-1 for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus

2023 · Xiujuan Chang, Shumin Yu, et al. · Journal of Hepatocellular Carcinoma · 3

P-146 Efficacy and safety of FLOT combined with apatinib and sintilimab as a neoadjuvant therapy regimen for locally advanced gastric or gastroesophageal junction adenocarcinoma: An open-lable, single-arm, phase II study

2023 · H. Zhou, B. Long, et al. · Annals of Oncology · 3

The efficacy and safety of transcatheter arterial chemoembolization combined with lenvatinib plus radiotherapy in the treatment of hepatocellular carcinoma: a meta-analysis

2024 · X. Wang, X. Xie, et al. · International Journal of Radiation Research · 1

Works count: 5

Citation count: 60

H-index: 3

I10-index: 1